These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 35387563)
21. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells. Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210 [TBL] [Abstract][Full Text] [Related]
22. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling. Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424 [TBL] [Abstract][Full Text] [Related]
23. [Neutrophil extracellular traps promote the proliferation, invasion and migration of prostate cancer cells by upregulating IL-8 expression in DU145 human prostate cancer cells]. Luo H; Chen G Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Mar; 39(3):261-267. PubMed ID: 36946351 [TBL] [Abstract][Full Text] [Related]
24. [Chinese medicinal compound CFF-1 induces the apoptosis and cycle-arrest of prostate cancer cells via the PI3K/AKT/FOXO1 signaling pathway]. Zhang Y; Wu ZM; Lei BH; Lu ZJ; Zhu QY; Xu FS; Zhang MS; Liu P Zhonghua Nan Ke Xue; 2017 Sep; 23(9):828-837. PubMed ID: 29726666 [TBL] [Abstract][Full Text] [Related]
25. Antiproliferative Activity of Carnosic Acid is Mediated via Inhibition of Cell Migration and Invasion, and Suppression of Phosphatidylinositol 3-Kinases (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway. Zhao L; Zhang J; Fan Y; Li Y Med Sci Monit; 2019 Oct; 25():7864-7871. PubMed ID: 31631173 [TBL] [Abstract][Full Text] [Related]
26. TGF-β effects on prostate cancer cell migration and invasion are mediated by PGE2 through activation of PI3K/AKT/mTOR pathway. Vo BT; Morton D; Komaragiri S; Millena AC; Leath C; Khan SA Endocrinology; 2013 May; 154(5):1768-79. PubMed ID: 23515290 [TBL] [Abstract][Full Text] [Related]
27. Polo-like kinase 4 mediates epithelial-mesenchymal transition in neuroblastoma via PI3K/Akt signaling pathway. Tian X; Zhou D; Chen L; Tian Y; Zhong B; Cao Y; Dong Q; Zhou M; Yan J; Wang Y; Qiu Y; Zhang L; Li Z; Wang H; Wang D; Ying G; Zhao Q Cell Death Dis; 2018 Jan; 9(2):54. PubMed ID: 29352113 [TBL] [Abstract][Full Text] [Related]
28. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion. Shukla S; Maclennan GT; Hartman DJ; Fu P; Resnick MI; Gupta S Int J Cancer; 2007 Oct; 121(7):1424-32. PubMed ID: 17551921 [TBL] [Abstract][Full Text] [Related]
29. Ganoderic acid A holds promising cytotoxicity on human glioblastoma mediated by incurring apoptosis and autophagy and inactivating PI3K/AKT signaling pathway. Cheng Y; Xie P J Biochem Mol Toxicol; 2019 Nov; 33(11):e22392. PubMed ID: 31503386 [TBL] [Abstract][Full Text] [Related]
30. AIM2 inhibits the proliferation, invasion and migration, and promotes the apoptosis of osteosarcoma cells by inactivating the PI3K/AKT/mTOR signaling pathway. Zheng J; Liu C; Shi J; Wen K; Wang X Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913077 [TBL] [Abstract][Full Text] [Related]
31. Overexpression of E74-Like Factor 5 (ELF5) Inhibits Migration and Invasion of Ovarian Cancer Cells. Zhang X; Lin J; Ma Y; Zhao J Med Sci Monit; 2019 Jan; 25():856-865. PubMed ID: 30696803 [TBL] [Abstract][Full Text] [Related]
32. Cleavage stimulation factor 2 promotes malignant progression of liver hepatocellular carcinoma by activating phosphatidylinositol 3'-kinase/protein kinase B/mammalian target of rapamycin pathway. Zhang MH; Liu J Bioengineered; 2022 Apr; 13(4):10047-10060. PubMed ID: 35412944 [TBL] [Abstract][Full Text] [Related]
33. Snail promotes cell migration through PI3K/AKT-dependent Rac1 activation as well as PI3K/AKT-independent pathways during prostate cancer progression. Henderson V; Smith B; Burton LJ; Randle D; Morris M; Odero-Marah VA Cell Adh Migr; 2015; 9(4):255-64. PubMed ID: 26207671 [TBL] [Abstract][Full Text] [Related]
34. The Upregulation of PI3K/Akt and MAP Kinase Pathways is Associated with Resistance of Microtubule-Targeting Drugs in Prostate Cancer. Liu Z; Zhu G; Getzenberg RH; Veltri RW J Cell Biochem; 2015 Jul; 116(7):1341-9. PubMed ID: 25640606 [TBL] [Abstract][Full Text] [Related]
35. Fetuin B overexpression suppresses proliferation, migration, and invasion in prostate cancer by inhibiting the PI3K/AKT signaling pathway. Zhan K; Liu R; Tong H; Gao S; Yang G; Hossain A; Li T; He W Biomed Pharmacother; 2020 Nov; 131():110689. PubMed ID: 32892030 [TBL] [Abstract][Full Text] [Related]
36. Oleanolic acid inhibits cell survival and proliferation of prostate cancer cells in vitro and in vivo through the PI3K/Akt pathway. Li X; Song Y; Zhang P; Zhu H; Chen L; Xiao Y; Xing Y Tumour Biol; 2016 Jun; 37(6):7599-613. PubMed ID: 26687646 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of PLK4 might enhance the anti-tumour effect of bortezomib on glioblastoma via PTEN/PI3K/AKT/mTOR signalling pathway. Wang J; Ren D; Sun Y; Xu C; Wang C; Cheng R; Wang L; Jia G; Ren J; Ma J; Tu Y; Ji H J Cell Mol Med; 2020 Apr; 24(7):3931-3947. PubMed ID: 32126150 [TBL] [Abstract][Full Text] [Related]
38. Berberine Affects the Proliferation, Migration, Invasion, Cell Cycle, and Apoptosis of Bladder Cancer Cells T24 and 5637 by Down-Regulating the HER2/PI3K/AKT Signaling Pathway. Li Q; Qing L; Xu W; Yang Y; You C; Lao Y; Dong Z Arch Esp Urol; 2023 Mar; 76(2):152-160. PubMed ID: 37139621 [TBL] [Abstract][Full Text] [Related]
39. Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells. Pfeil K; Eder IE; Putz T; Ramoner R; Culig Z; Ueberall F; Bartsch G; Klocker H Prostate; 2004 Feb; 58(3):259-68. PubMed ID: 14743465 [TBL] [Abstract][Full Text] [Related]
40. The Impact of Icariside II on Human Prostate Cancer Cell Proliferation, Mobility, and Autophagy via PI3K-AKT-mTOR Signaling Pathway. Li S; Zhan Y; Xie Y; Wang Y; Liu Y Drug Des Devel Ther; 2020; 14():4169-4178. PubMed ID: 33116405 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]